Many Patients Not Given FDA-Advised Starting Dose of Medications, Study Finds

Many Patients Not Given FDA-Advised Starting Dose of Medications, Study Finds
About two-thirds of fibromyalgia patients do not get the starting dose recommended by the FDA in the label it places on an approved medication, a recent study that looked at data collected on thousands of patients over nine years reports. Currently there are three medications approved by the U.S. Food and Drug Administration (FDA) for the treatment of fibromyalgia: Lyrica (pregabalin), Cymbalta (duloxetine) and Savella (milnacipran).  "Only approximately 34% of patients were prescribed FDA-approved drugs for fibromyalgia at the recommended starting dose," the researchers wrote.    Real-world considerations of physicians' prescribing patterns are behind this practice.  "The appropriate dose of fibromy
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *